TY - JOUR
T1 - Health-related quality of life after transcatheter or surgical aortic valve replacement in high-risk patients with severe aortic stenosis
T2 - An updated review of literature
AU - Chatterjee, Saurav
AU - Kumbhani, Dharam Jaydeep
AU - Sardar, Partha
AU - Chakraborty, Anasua
AU - Biondi-Zoccai, Giuseppe
AU - Sabharwal, Manpreet Singh
AU - Ro, Richard
AU - Pratap, Balaji
AU - Bavishi, Chirag P.
AU - Bangalore, Sripal
PY - 2014/4
Y1 - 2014/4
N2 - Recent trials have highlighted the comparable mortality benefits and durability of the results for patients with severe aortic stenosis (AS) and high surgical risk managed with either transcatheter aortic valve replacement (TAVR) or surgical aortic valve replacement (AVR). Various national guidelines and international regulatory bodies have approved TAVR, thereby leading to potential wide usage and dissemination of this technique worldwide. Quality-of-life outcomes, in spite of being an important measure of success and acceptability of the procedure, have not been publicized as extensively. For high risk patients with severe AS, implementation of TAVR has resulted in comparable survival, but different and novel adverse events compared with AVR. We present an updated review focusing on the quality-of-life outcomes and issues with this new and important procedural approach.
AB - Recent trials have highlighted the comparable mortality benefits and durability of the results for patients with severe aortic stenosis (AS) and high surgical risk managed with either transcatheter aortic valve replacement (TAVR) or surgical aortic valve replacement (AVR). Various national guidelines and international regulatory bodies have approved TAVR, thereby leading to potential wide usage and dissemination of this technique worldwide. Quality-of-life outcomes, in spite of being an important measure of success and acceptability of the procedure, have not been publicized as extensively. For high risk patients with severe AS, implementation of TAVR has resulted in comparable survival, but different and novel adverse events compared with AVR. We present an updated review focusing on the quality-of-life outcomes and issues with this new and important procedural approach.
KW - Health-related quality of life
KW - High-risk patients
KW - Severe aortic stenosis
KW - Surgical aortic valve replacement
KW - Transapical
KW - Transcatheter aortic valve replacement
KW - Transfemoral
UR - http://www.scopus.com/inward/record.url?scp=84894429779&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84894429779&partnerID=8YFLogxK
U2 - 10.1007/s11886-014-0473-8
DO - 10.1007/s11886-014-0473-8
M3 - Article
C2 - 24585114
AN - SCOPUS:84894429779
SN - 1523-3782
VL - 16
JO - Current Cardiology Reports
JF - Current Cardiology Reports
IS - 4
M1 - 473
ER -